Cholinesterase-restoring agents in the therapy of experimental tetanus.
D000818:Animals; D002802:Cholinesterases / Q000097:blood; D004198:Disease Susceptibility; D004357:Drug Synergism; D006168:Guinea Pigs; D006736:Horses; D008274:Magnesium / Q000627:therapeutic use; D010527:Perissodactyla; D011220:Pralidoxime Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D013742:Tetanus / Q000188:drug therapy* / Q000201:enzymology / Q000209:etiology / Q000401:mortality; D013743:Tetanus Antitoxin / Q000008:administration & dosage / Q000627:therapeutic use; D013744:Tetanus Toxin; D013997:Time Factors; D014805:Vitamin B 12 / Q000008:administration & dosage / Q000627:therapeutic use
D011220:Pralidoxime Compounds; D013743:Tetanus Antitoxin; D013744:Tetanus Toxin; D002802:Cholinesterases; D008274:Magnesium; D014805:Vitamin B 12